US · USD
CORT
Corcept Therapeutics Incorporated
- Day's range
- $115.50 – $122.81
- Day's volume
- $121.4M
- 52-week range
- $32.15 – $123.57
Follow CORT in the Fuolio
See how CORT weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountCORT in numbers
- Market cap
- $13.2B
- P/E
- 239.05
- P/B
- 18.69
- Dividend yield (12m)
- 0.00%
CORT trades at 239.05 times its earnings of the last 12 months.
CORT price history
CORT risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +53.69% | +379.11% | +481.10% |
| Volatility (annualized) | 89.38% | 87.12% | 72.90% |
| Largest drawdown | -56.17% | -69.53% | -69.53% |
| Positive months | 9/12 | 24/36 | 36/60 |
How much did investing in CORT return?
$1,000.00 invested on 11/01/2021 would be worth $5,810.95 today.
- Value today in CORT
- $5,810.95
- Return over the period
- +481.10%
- Return per year
- +42.94%
- In the S&P 500
- $1,702.20
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
CORT fundamentals
Valuation
- P/E239.05
- P/B18.69
- EV/EBITDA1,631.77
- EV/EBIT2,059.52
- EV/Revenue15.88
- P/EBIT2,059.52
- P/S15.88
- P/OCF120.25
- P/FCF123.37
- Earnings yield0.05%
- PEG ratio—
- Earnings per share$0.51
- Book value per share$6.53
Debt
- Net debt—
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio2.86
- Quick ratio2.77
- Cash ratio2.00
Efficiency
- Gross margin98.30%
- EBITDA margin0.97%
- Operating margin0.77%
- Net margin6.64%
- Asset turnover0.93
Profitability
- ROE7.82%
- ROA6.21%
- ROIC0.91%
- Payout0.00%
Growth
- Revenue CAGR (5 years)19.35%
- Earnings CAGR (5 years)-10.78%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is CORT's fair price?
Two classic value formulas, with today's numbers. The current price is $122.03.
- Graham's fair price
- $8.66
- 92.90% below the price
√(22.50 × $0.51 × $6.53)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- —
- Does not apply to CORT: it paid no distributions in the last five years.
Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.
Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.
CORT's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 37.15 | 37.65 | 31.68 | 21.61 | 18.65 | 28.95 | 14.72 | 20.32 |
| P/B | 5.71 | 7.82 | 6.64 | 4.37 | 5.58 | 5.86 | 3.74 | 5.56 |
| EV/EBITDA | 80.57 | 38.60 | 31.04 | 19.24 | 16.71 | 23.84 | 12.35 | 17.08 |
| Earnings per share | $0.94 | $1.34 | $1.03 | $0.94 | $1.06 | $0.90 | $0.82 | $0.66 |
| Book value per share | $6.09 | $6.44 | $4.89 | $4.65 | $3.55 | $4.46 | $3.24 | $2.40 |
| ROE | 15.38% | 20.78% | 20.95% | 20.21% | 29.94% | 20.26% | 25.37% | 27.33% |
| ROIC | 6.92% | 17.62% | 18.04% | 19.59% | 29.81% | 19.73% | 24.27% | 26.55% |
| Gross margin | 98.30% | 98.39% | 98.66% | 98.66% | 98.56% | 98.42% | 98.20% | 97.92% |
| EBITDA margin | 6.03% | 20.41% | 22.46% | 28.34% | 34.31% | 36.38% | 36.64% | 35.71% |
| Net margin | 13.09% | 20.92% | 22.00% | 25.24% | 30.74% | 29.96% | 30.73% | 30.01% |
CORT's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $761.4M | $675M | $482.4M | $401.9M | $366M | $353.9M |
| Cost of revenue | -$13M | -$10.9M | -$6.5M | -$5.4M | -$5.3M | -$5.6M |
| Gross profit | $748.4M | $664.2M | $475.9M | $396.5M | $360.7M | $348.3M |
| EBITDA | $45.9M | $137.7M | $108.3M | $113.9M | $125.5M | $128.7M |
| EBIT | $44.8M | $137M | $107.3M | $112.6M | $124.5M | $128.2M |
| Financial result | $21.7M | $24.5M | $17.3M | $3.6M | $529K | — |
| Income before tax | $66.5M | $161.5M | $124.6M | $116.2M | $125M | $131.6M |
| Income tax | $33.2M | -$20.3M | -$18.4M | -$14.8M | -$12.5M | -$25.6M |
| Net income | $99.7M | $141.2M | $106.1M | $101.4M | $112.5M | $106M |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does CORT pay dividends?
CORT has no distributions on record.
About Corcept Therapeutics Incorporated
- Sector
- Manufacturing
Questions about CORT
How much is CORT today?
CORT is at $122.03 (4.99% on the day), last traded on 10/05/2026.
What are the P/E and P/B of CORT?
CORT trades at a P/E of 239.05 and a P/B of 18.69.
How much did CORT return in 12 months?
CORT returned 53.69% in 12 months, with annualized volatility of 89.38% and a largest drawdown of -56.17%.